Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gheath Alatrash

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Oncoimmunology|June 5, 2013
Targeting cathepsin G in myeloid leukemiaGheath Alatrash
Expert Review of Hematology|February 17, 2011
Vaccines as consolidation therapy for myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem
Blood|September 18, 2010
Immune rage against MAGE unleashedJeffrey J Molldrem, Gheath Alatrash
Cancer Treatment and Research|March 23, 2010
Immunotherapy of AMLGheath Alatrash, Jeffrey J Molldrem
Pharmacological Reviews|September 25, 2016
Targeting Immune Checkpoints in Hematologic MalignanciesGheath Alatrash, Naval Daver, Elizabeth A Mittendorf
Oncotarget|February 14, 2018
Targeting PR1 in myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem, Muzaffar H Qazilbash
Mayo Clinic Proceedings|April 14, 2006
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivativeGheath Alatrash, Navneet S Majhail, James C Pile
Breast Cancer Management|February 12, 2014
Immune aspects of the breast tumor microenvironmentAkhil Chawla, Gheath Alatrash, Yun Wu, et al.
Oncoimmunology|May 21, 2014
Immune checkpoints: A therapeutic target in triple negative breast cancerAkhil Chawla, Anne V Philips, Gheath Alatrash, et al.
Expert Opinion on Drug Safety|May 15, 2013
Cancer immunotherapies, their safety and toxicityGheath Alatrash, Haroon Jakher, Patricia D Stafford, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Oncoimmunology|June 5, 2013
Targeting cathepsin G in myeloid leukemiaGheath Alatrash
Expert Review of Hematology|February 17, 2011
Vaccines as consolidation therapy for myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem
Blood|September 18, 2010
Immune rage against MAGE unleashedJeffrey J Molldrem, Gheath Alatrash
Cancer Treatment and Research|March 23, 2010
Immunotherapy of AMLGheath Alatrash, Jeffrey J Molldrem
Pharmacological Reviews|September 25, 2016
Targeting Immune Checkpoints in Hematologic MalignanciesGheath Alatrash, Naval Daver, Elizabeth A Mittendorf
Oncotarget|February 14, 2018
Targeting PR1 in myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem, Muzaffar H Qazilbash
Mayo Clinic Proceedings|April 14, 2006
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivativeGheath Alatrash, Navneet S Majhail, James C Pile
Breast Cancer Management|February 12, 2014
Immune aspects of the breast tumor microenvironmentAkhil Chawla, Gheath Alatrash, Yun Wu, et al.
Oncoimmunology|May 21, 2014
Immune checkpoints: A therapeutic target in triple negative breast cancerAkhil Chawla, Anne V Philips, Gheath Alatrash, et al.
Expert Opinion on Drug Safety|May 15, 2013
Cancer immunotherapies, their safety and toxicityGheath Alatrash, Haroon Jakher, Patricia D Stafford, et al.
Pageof 8